Erfecto Tablet (Erdostein)

Adult dose

Adults: Administer erdosteine 300 mg orally 2~3 times daily. When administered for acute respiratory disease, do not administer continuously for more than 10 days.

This medication should not be used in certain patients. First, individuals allergic to this medication or its components should not take it. Patients with liver cirrhosis or those who lack the enzyme cystathionine synthase should avoid this medication as its metabolites may interfere with the metabolism of methionine in the body. Patients with peptic ulcers should also avoid using this medication. Those with severe renal impairment, especially with a creatinine clearance of less than 25 mL/min, should refrain from using this medication. Moreover, patients with severe liver impairment should not take this medication. This drug contains lactose, so individuals with genetic disorders such as lactose intolerance, galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption should not take it. Patients with mild to moderate liver impairment should use this medication cautiously and ensure the daily dosage does not exceed 300 mg. Diabetic patients or those on a low-calorie diet should also be careful when using the syrup formulation of this medication. In case of overdose, symptoms such as excessive sweating, dizziness, and facial flushing may occur. Gastrointestinal symptoms may also arise, including headache, cold symptoms, shortness of breath, altered taste, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Skin reactions could include hives, red spots, and eczema. Additionally, symptoms like fatigue, dyspepsia, palpitations, facial or systemic swelling, itching, weakness, confusion, and rash have also been reported. Taking this medication with expectorants may increase the risk of bronchial infection due to difficulty in expelling sputum caused by cough relief, and problems may arise in the contraction or relaxation of the bronchi, so caution is advised. Pregnant or potentially pregnant women and nursing mothers should avoid this medication as its safety is not clearly established. This medication should be kept out of the reach of children and caution should be taken to avoid transferring it to another container as this could cause accidents or be detrimental to the quality of the medication.

• Sweating
• dizziness
• flushing
• headache
• cold
• dyspnea
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

Consult with a doctor or pharmacist if this medication is to be taken with cough medicines.

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. This way of storage will help maintain the medication's efficacy for a longer time.

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle - 30 tablets/bottle, 30 tablets/bottle, 300 tablets/bottle - 300 tablets/bottle